Abstracts Archive - Page 508 of 1683 - ATC Abstracts

2020 American Transplant Congress
Improvement of Renal Function Prior to Liver Transplantation is Not Associated with Better Long-Term Renal Outcome or Mortality
M. Sterneck¹, T. Horvatits², M. Touma², U. Herden³, A. Lohse², L. Fischer³
¹University Medical Center Hamburg Eppendorf, Hamburg, Germany, ²Department of Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany, ³Transplant Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
*Purpose: Since introduction of the MELD score in the liver allocation system, renal impairment in OLT recipients has become a topic of increasing importance. This…
2020 American Transplant Congress
Association between Longer Hospitalization and Development of De Novo Donor Specific Antibody in Simultaneous Liver-Kidney Transplant Recipients
M. Yazawa¹, O. Cseprekal², R. A. Helmick¹, M. Talwar¹, V. Balaraman¹, P. S. Podila³, S. Fossey⁴, S. K. Satapathy⁵, J. D. Eason¹, M. Z. Molnar¹
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary, ³Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN, ⁴Transplant Immunology Laboratory, DCI Inc., Nashville, TN, ⁵Sandra Atlas Bass Center for Liver Diseases & Transplantation, Northshore University Hospital/Northwell Health, Manhasset, NY
*Purpose: De novo Donor Specific Antibodies (DSA) are considered a risk factor for worsening kidney allograft outcomes in recipients after simultaneous liver-kidney transplantation (SLK). No…
2020 American Transplant Congress
De Novo Use of Envarsus (LCPT) in African American and Elderly Kidney Transplant Recipients: An Early Single Center Experience
N. Wilson¹, R. Leek¹, R. Forbes², D. Shaffer², S. Rega³, I. Feurer³, B. Concepcion⁴, A. Langone⁴
¹Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, ²Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, ³Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN, ⁴Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Clinical trials with LCPT have shown a steadier and more consistent concentration time profile over 24 hours with increased bioavailability compared to twice daily…
2020 American Transplant Congress
Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Treatment of Patients with Hepatitis B Following Liver Transplantation
C. Cheng
Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Kwei-Shan Township, Taoyuan, Taiwan
*Purpose: Taiwan has a high prevalence of hepatitis B (HBV) and HBV related end-stages liver diseases are the leading causes of liver transplantation (LT). Tenofovir…
2020 American Transplant Congress
Delayed Graft Function in the Recipients of Simultaneous Liver and Kidney Transplant: A Single-Center Experience
F. Aziz, B. Muth, N. Garg, M. Mohamed, D. Mandelbrot, J. Mezrich, A. Djamali, S. Parajuli
University of Wisconsin, Madison, WI
*Purpose: Increased rates of delayed graft function (DGF) have been reported in the recipients of simultaneous liver and kidney (SLK) transplant. However, the effect of…
2020 American Transplant Congress
Renal Safety of Entecavir and Tenofovir with Hepatitis B Immunoglobulin in Liver Transplant Patients
J. Lee¹, E. Kim¹, S. Yang¹, D. Kim², S. Kim¹, J. Park³, H. Choi⁴, B. Kim³, D. Joo¹, M. Kim¹, S. Kim¹, J. Lee¹
¹Department of Transplantation Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ²Department of Surgery, Wonju Severance Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of, ³Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ⁴Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: Combination of potent nucleos(t)ide analougues (NAs) and hepatitis B immunoglobulin is recommended after liver transplantation for the prevention of hepatitis B virus (HBV) recurrence.…
2020 American Transplant Congress
Post-Transplant Renal Function in ACLF Patients Based on Pre-Transplant Severity of Renal Dysfunction without Kidney Transplant
M. Yazawa¹, B. Maliakkal¹, S. Nair¹, Y. Jiang², P. S. Podila³, U. A. Agbim¹, S. Karri⁴, S. D. Khan⁵, D. Maluf¹, J. D. Eason¹, M. Z. Molnar¹, S. K. Satapathy⁶
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Division of Epidemiology, Biostatistics, and Environmental Health, The University of Memphis, Memphis, TN, ³Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN, ⁴Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, ⁵Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, ⁶Sandra Atlas Bass Center for Liver Diseases & Transplantation, Department of Medicine, Northshore University Hospital/Northwell Health, Manhasset, NY
*Purpose: It is unknown whether severity of renal dysfunction in ACLF patients impacts outcome of ACLF patients compared to those without ACLF.*Methods: In a single…
2020 American Transplant Congress
Intraoperative Oxygen Delivery and Acute Kidney Injury after Liver Transplantation
W. Kim, H. Lee, H. Yoon, K. Suh
Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Although intraoperative hemodynamic variables were reported to be associated with acute kidney injury (AKI) after liver transplantation, the time-dependent association between intraoperative oxygen delivery…
2020 American Transplant Congress
Effects of Tenofovir and Entecavir on Glomerular Kidney Function in Liver Transplant Patients: A Nationwide Cohort Study
J. Lee¹, E. Kim¹, S. Yang¹, S. Kim¹, J. Lee¹, J. Park², H. Choi³, B. Kim², D. Joo¹, S. Kim¹, M. Kim¹
¹Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, ²Department of Internal Medicine, Severance Hospital, Seoul, Korea, Republic of, ³Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of
*Purpose: Entecavir and tenofovir are currently the first-line drugs in liver transplantation (LT) patients for the prevention of hepatitis B virus recurrence. Despite its proven…
2020 American Transplant Congress
Optimal Timing of Initiating Continuous Renal Replacement Therapy in Patients with Acute Kidney Injury after Liver Transplantation
A. Ren, Z. Li, X. Zhang, R. Deng, Y. Ma
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
*Purpose: Acute kidney injury(AKI) is a frequent complication after liver transplantation(LT), and is associated with high mortality. Continuous Renal Replacement Therapy (CRRT) is a blood…